JP Morgan Chase
THTX

JP Morgan Chase’s Theratechnologies THTX Stock Holding History

JP Morgan Chase’s Portfolio THTX Stock Details THTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-34,924
Closed -$48.9K – 7634
2025
Q1 		$48.9K Buy
34,924
+16,800
+93% +$28.1K ﹤0.01% 5890
2024
Q4 		$32.8K Buy
+18,124
New +$24.6K ﹤0.01% 6137

Other funds holding THTX

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

JP Morgan Chase's THTX Position: Q2 2025 in Review

JP Morgan Chase sold out of Theratechnologies (THTX) in Q2 2025, closing a stake of 34,924 shares — an estimated $48.9K sold.

JP Morgan Chase first reported a position in THTX in Q4 2024 and held it in 2 quarters. The position peaked at $48.9K in Q1 2025. 49 funds tracked by Wall St. Rank hold THTX as of Q2 2025.

  • JP Morgan Chase reported no remaining Theratechnologies position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 34,924 Theratechnologies shares in Q2 2025, an estimated $48.9K.
  • JP Morgan Chase first reported a position in Theratechnologies in Q4 2024 and held it in 2 quarters.
  • JP Morgan Chase's Theratechnologies position peaked at $48.9K in Q1 2025.
  • 49 funds tracked by Wall St. Rank held Theratechnologies as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.